Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
7.79
-0.00 (-0.06%)
At close: May 29, 2025, 3:59 PM
7.90
1.41%
After-hours: May 29, 2025, 07:06 PM EDT
-0.06% (1D)
| Bid | 7 |
| Market Cap | 52.94M |
| Revenue (ttm) | 101.58M |
| Net Income (ttm) | -15.64M |
| EPS (ttm) | -2.26 |
| PE Ratio (ttm) | -3.45 |
| Forward PE | -5.53 |
| Analyst | Buy |
| Ask | 8.2 |
| Volume | 76,873 |
| Avg. Volume (20D) | 58,913 |
| Open | 7.89 |
| Previous Close | 7.79 |
| Day's Range | 7.53 - 8.10 |
| 52-Week Range | 5.00 - 18.70 |
| Beta | 0.30 |
About ATRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+15.13%
Atara Biotherapeutics shares are trading higher af...
Unlock content with
Pro Subscription
3 weeks ago
+5.79%
Atara Biotherapeutics shares are trading higher after the company provided updates on EBVALLO and announced the FDA has lifted its clinical hold to resume the clinical trials.
